Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001096906-12-002482
Filing Date
2012-10-01
Accepted
2012-10-01 10:44:34
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10QA1 2012-03-31 aoxing10qa120020331.htm 10-Q/A 1053348
2 RULE 13A-14(A) CERTIFICATION ? CEO aoxingexh311.htm EX-31.1 9666
3 RULE 13A-14(A) CERTIFICATION ? CFO aoxingexh312.htm EX-31.2 9771
4 RULE 13A-14(B) CERTIFICATION aoxingexh32.htm EX-32 6561
  Complete submission text file 0001096906-12-002482.txt   3886218

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT axn-20120331.xml EX-101.INS 758588
6 XBRL SCHEMA DOCUMENT axn-20120331.xsd EX-101.SCH 11906
7 XBRL CALCULATION LINKBASE DOCUMENT axn-20120331_cal.xml EX-101.CAL 7301
8 XBRL LABELS LINKBASE DOCUMENT axn-20120331_def.xml EX-101.DEF 58672
9 XBRL PRESENTATION LINKBASE DOCUMENT axn-20120331_lab.xml EX-101.LAB 99880
10 XBRL DEFINITION LINKBASE DOCUMENT axn-20120331_pre.xml EX-101.PRE 76991
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 001-32674 | Film No.: 121118689
SIC: 2834 Pharmaceutical Preparations